There are fewer than 500 board-certified adult congenital heart disease specialists in the U.S., according to a study published July 1 in the American Journal of Cardiology, while the number of adults ...

A recent study of outcomes in infants and young deaf children with cochlear implants (implanted electronic hearing device), ...

Benlysta is supplied as a single-dose prefilled autoinjector or prefilled syringe containing 200mg/mL of belimumab for SC use. The prefilled syringe has not been studied in pediatric patients aged ...

Adult and Pediatric Clinical Trials of Sublingual Immunotherapy in the USA Dai Park; Nora Daher; Michael S Blaiss Disclosures Expert Rev Clin Immunol. 2012;8 (6):557-564. Abstract and Introduction ...

Adult Film Star Blasts WNBA For Caitlin Clark Treatment first appeared on The Spun on Jun 18, 2025 This story was originally reported by The Spun on Jun 18, 2025, where it first appeared.

Avata Biosciences Holdings Ltd (‘Avata’), a pioneering biopharmaceutical company specializing in neuroscience drug discovery and clinical development, today announced it has signed a co ...

Avata Biosciences Signs Co-Development and Licensing Agreement with Oceanus Bio for Exclusive Rights in Japan and Asia (Excluding China and India) for Novel Adult and Pediatric Oral Cannabidiol ...

Agreement includes $95m in co-development contributions and milestones, and additionally double-digit royalty payments to Avata AVAT-021 is a solid dose cannabidiol for clinical development in adult ...

Simmonds M, Llewellyn A, Owen CG, Woolacott N. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes Rev. 2016;17 (2):95-107. doi:10.1111/obr.12334 ...

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23 Published ...

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled ...